SLC5A2 and diabetes mellitus: Most of the heterogeneous factors (eg, variability of the ocular surface) are unlikely to have affected clinician decision-making on whether to prescribe SGLT2 inhibitors or GLP-1 RAs, but other factors, such as patients’ baseline diabetes severity and adherence to drugs, may have played a greater role.